Trial Profile
A Double-blind, Randomized Controlled Trial of the Effect of Vaccine Inoculum on Oral Rotavirus Vaccine (Rotarix, GlaxoSmithKline) Take and Immunogenicity in Dhaka, Bangladesh
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- 10 Oct 2019 Results published in the Vaccine
- 15 Oct 2018 Status changed from active, no longer recruiting to completed.
- 16 May 2018 Status changed from recruiting to active, no longer recruiting.